Table 1.
Challenegs and applications of detection technologies.
Detection method | Challenges. | Application of detection methods to superbugs or the novel coronavirus (SARS-CoV-2) |
---|---|---|
Biosensor-based method | • Sensitivity to pH, change of mass, and temperature [24] • Difficult for biosensors to apply to real-world environmental samples (e.g., interfering microbial species, particulate matter, and humic substances) [25] |
Staphylococcus Bacteria [15] |
Fluorescence in situ hybridization (FISH) | • Low sensitivity • Pre-enrichment and concentration steps [17] |
Ampicillin-resistant Escherichia coli [16] |
Surface-enhanced Raman spectroscopy (SERS) | • Matrix interference and spectra changes during measurement [19] • High cost of the confocal micro-Raman instrument • Need for user-friendly software • Not applicable for field monitoring settings |
• Methicillin-resistant S. aureus (MRSA) / • Pseudomonas. aeruginosa [18] |
Polymerase chain reaction (PCR) [20] |
• Accurate primers and optimal reaction mixture are required to avoid faulty results [17,22]. | Novel coronavirus (SARS-CoV-2), with an N_Sarbeco qPCR assay following the electronegative membrane-vortex (ENV) method [21] |
Nanofiber filters (application of a nanofiber membrane at a pretreatment process stage) |
• High risk of losing functionality of agents (e.g., nanosilver and bronopol) applied for electrospun membranes during leaching [23] • Interference from inhibitors in field samples during nanofiber membrane filtration |
Novel coronavirus (SARS-CoV-2) [23] |
Factors for development of detection methods • Detecting low concentration of pathogens • Sensitivity, automation, reproducibility, and specificity • Speed (close-to-real-time detection of viruses and bacteria) • Low cost; alleviating interactions among pathogens • Elimination of inhibitors |